Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors

被引：79

作者：

Chen, Jianyong

Bai, Longchuan

Bernard, Denzil

Nikolovska-Coleska, Zaneta

Gomez, Cindy

Zhang, Jian

Yi, Han

Wang, Shaomeng ^{[1
]}

机构：

[1] Univ Michigan, Ctr Comprehens Canc, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2010年 / 1卷 / 02期

关键词：

STAT3; inhibitor; SH2; domain; apoptosis; SOLID-PHASE SYNTHESIS; SIGNAL TRANSDUCER; SMALL-MOLECULE; PEPTIDOMIMETIC INHIBITORS; SH2; DOMAIN; DIMERIZATION; ACTIVATOR; TARGETS; BINDING; PHOSPHOPEPTIDES;

D O I：

10.1021/ml100010j

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We report herein the structure-based design of a class of conformationally constrained, potent, cell-permeable small-molecule inhibitors to target the SH2 domain in STAT3. Compound 11 (CJ-1383) binds to STAT3 with a K-i value of 0.95 mu M, dose-dependently inhibits cellular STAT3 signaling and cancer cell growth, and induces apoptosis in the MDA-MB-468 cancer cell line with constitutively activated STAT3.

引用

页码：85 / 89

页数：5

共 50 条

[31] Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins
Iqbal, Shazia
Islam, Md. Zahidul
Ashraf, Sajda
Kim, Woonghee
AL-Sharabi, Amal A.
Ozcan, Mehmet
Hanashalshahaby, Essam
Zhang, Cheng
Uhlen, Mathias
Boren, Jan
Turkez, Hasan
Mardinoglu, Adil
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
[32] Tetrapodal Stat3 inhibitors offer potent disruption of Stat3 in vitro and in whole cell assays
Page, Brent D. G.
Schimmer, Aaron
Turkson, James
Gunning, Patrick T.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[33] MEDI 344-Structure-based design and synthesis of conformationally constrained inhibitors of parasitic cysteine proteases
Chen, Yen Ting
Lira, Ricardo
Reddick, Jason J.
Hansell, Elizabeth
McKerrow, James H.
Roush, William R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[34] Design, synthesis, and studies of small molecule STAT3 inhibitors
Bhasin, Deepak
Cisek, Katryna
Pandharkar, Trupti
Regan, Nicholas
Li, Chenglong
Pandit, Bulbul
Lin, Jiayuh
Li, Pui-Kai
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 391 - 395
[35] The development of peptide-based inhibitors of Stat3α
Ren, Zhiyong
Coleman, David R.
Cabell, Larry A.
McMurray, John S.
PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 550 - 552
[36] MEDI 122-Toward the design of cell-permeable cap-dependent translation inhibitors
Jia, Yan
Wagner, Carston R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[37] Structure-Based Design of Covalent Siah Inhibitors
Stebbins, John L.
Santelli, Eugenio
Feng, Yongmei
De, Surya K.
Purves, Angela
Motamedchaboki, Khatereh
Wu, Bainan
Ronai, Ze'ev A.
Liddington, Robert C.
Pellecchia, Maurizio
CHEMISTRY & BIOLOGY, 2013, 20 (08): : 973 - 982
[38] STRUCTURE-BASED DESIGN OF CALCINEURIN INHIBITORS.
Kissinger, Charles R.
Parge, Hans
Knighton, Daniel
Pelletier, Laura
Tempczyk, Anna
Tatlock, John
Villafranca, Ernest
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C201 - C201
[39] Structure-based design of macrocyclic kinase inhibitors
Poulsen, Anders
Wiliam, Anthony D.
Blanchard, Steephanie
Dymock, Brian
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[40] Structure-based design of Aurora A & B inhibitors
Anders Poulsen
Anthony William
Angeline Lee
Stéphanie Blanchard
Eeling Teo
Weiping Deng
Noah Tu
Evelyn Tan
Eric Sun
Kay Lin Goh
Wai Chung Ong
Chee Pang Ng
Kee Chuan Goh
Zahid Bonday
Journal of Computer-Aided Molecular Design, 2008, 22 : 897 - 906

← 1 2 3 4 5 →